Works matching IS 03125963 AND DT 2007 AND VI 46 AND IP 12

Results: 4

Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients: a study by the EORTC-PAMM-NDDG.
Published in:
2007
By:
- Joerger, Markus;
- Huitema, Alwin D. R.;
- Richel, Dick J.;
- Dittrich, Christian;
- Pavlidis, Nikolas;
- Briasoulis, Evangelos;
- Vermorken, Jan B.;
- Strocchi, Elena;
- Martoni, Andrea;
- Sorio, Roberto;
- Sleeboom, Henk P.;
- Izquierdo, Miguel A.;
- Jodrell, Duncan I.;
- Féty, Réegine;
- de Bruijn, Ernst;
- Hempel, Georg;
- Karlsson, Mats;
- Tranchand, Brigitte;
- Schrijvers, Ad H. G. J.;
- Twelves, Chris
Publication type:
journal article
Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies.
Published in:
2007
By:
- Eberl, Sonja;
- Renner, Bertold;
- Neubert, Antje;
- Reisig, Mareike;
- Bachmakov, Iouri;
- Köonig, Jörg;
- Döorje, Frank;
- Müurdter, Thomas E.;
- Ackermann, Andreas;
- Dormann, Harald;
- Gassmann, Karl G.;
- Hahn, Eckhart G.;
- Zierhut, Stefanie;
- Brune, Kay;
- Fromm, Martin F.;
- König, Jörg;
- Dörje, Frank;
- Mürdter, Thomas E
Publication type:
journal article
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.
Published in:
2007
By:
- Pea, Federico;
- Viale, Pierluigi;
- Pavan, Federica;
- Furlanut, Mario
Publication type:
journal article
Antiarrhythmics: elimination and dosage considerations in hepatic impairment.
Published in:
2007
By:
- Klotz, Ulrich
Publication type:
journal article

Works matching IS 03125963 AND DT 2007 AND VI 46 AND IP 12

Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients: a study by the EORTC-PAMM-NDDG.

Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies.

Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.

Antiarrhythmics: elimination and dosage considerations in hepatic impairment.